The parade of Massachusetts biotech startups seeking to go public continued Monday, when Cerulean Pharma Inc. registered with regulators to raise up to $75 million to bankroll clinical trials of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback